#Coronavirus #COVID19 stocks
section added to Biotech stocks directory
New Crypto and Biotech Stocks
added to Investor Ideas
Nasdaq/Nyse IPO’s in Biotech,
Luxury Retail, Real Estate, Sports, Restaurants and China-Asia
Point Roberts WA, Delta BC, February 28, 2020 –
(Investorideas.com Newswire) Investorideas.com, a global news source and
leading investor resource announces its weekly roundup of stocks added to its global
stock directories in biotech, retail, real estate, sports, food & beverage
(restaurants), China-Asia and crypto.
This week’s new companies includes many Nasdaq/NYSE
IPO’s in biotech and life sciences, retail, real estate, sports (boating), food
and beverage (restaurants) and a new China-Asia IPO involved in insurance
products and services or customers in China.
Also new this week is the TSX Venture listed crypto
company, Bitfarms Ltd. (TSXV:BITF.V) and biotech companies – including some who
are working on Coronavirus solutions.
Be sure to check out the updated Biotech Stocks
Directory which now includes stocks involved in combating Coronavirus (COVID19)
– according to company news and commentary.
https://www.investorideas.com/BIS/stock_list.asp
Evelo Biosciences,
Inc. (Nasdaq:EVLO) is a clinical stage biotechnology company developing oral biologics
that act on SINTAX with systemic therapeutic effects. SINTAX plays a central
role in governing the immune, metabolic and neurological systems. The company’s
first product candidates are monoclonal microbials, single strains of microbes
selected for defined pharmacological properties. Evelo’s therapies have the
potential to be effective, safe and affordable medicines to improve the lives
of people with chronic diseases and cancer. Evelo currently has four product
candidates: EDP1815, EDP1867, and EDP2939 for the treatment of inflammatory
diseases, and EDP1503 for the treatment of cancer. Evelo is also advancing
additional oral biologics through preclinical development in other disease areas.
Vaxart (NasdaqGS:
VXRT) is a
clinical-stage biotechnology company focused on developing oral recombinant
protein vaccines based on its proprietary oral vaccine platform. Vaxart’s
vaccines are designed to generate broad and durable immune responses that
protect against a wide range of infectious diseases and may also be useful for
the treatment of chronic viral infections and cancer. Vaxart’s vaccines are
administered using a convenient room temperature-stable tablet, rather than by
injection. Vaxart believes that tablet vaccines are easier to distribute and
administer than injectable vaccines and have the potential to significantly
increase vaccination rates. Vaxart’s development programs include oral tablet
vaccines that are designed to protect against norovirus, seasonal influenza and
respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human
papillomavirus (HPV).
Cocrystal Pharma, Inc. (NasdaqCM: COCP) is a clinical stage biotechnology company discovering and
developing novel antiviral therapeutics that target the replication machinery
of influenza viruses, hepatitis C viruses, noroviruses and coronaviruses.
Enlivex Therapeutics Ltd. (NasdaqCM:ENLV) is a clinical stage immunotherapy company, developing an
allogeneic drug pipeline for immune system rebalancing. Immune system
rebalancing is critical for the treatment of life-threatening immune and
inflammatory conditions which involve an out of control immune system (e.g.
Cytokine Release Syndrome) and for which there are no approved treatments
(unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Beyond
Air, Inc. (NasdaqCM:XAIR) is a clinical-stage medical device and
biopharmaceutical company developing a revolutionary NO Generator and Delivery
System, LungFit™ that uses NO generated from ambient air to deliver precise
amounts of NO to the lungs for the potential treatment of a variety of
pulmonary diseases. The LungFit™ can generate up to 400 ppm of NO for delivery
either continuously or for a fixed amount of time and has the ability to either
titrate dose on demand or maintain a constant dose. The Company is currently
applying its therapeutic expertise to develop treatments for pulmonary
hypertension in various settings, in addition to treatments for lower
respiratory tract infections that are not effectively addressed with current
standards of care. Beyond Air is currently advancing its revolutionary LungFit™
in clinical trials for the treatment of bronchiolitis and severe lung
infections such as nontuberculous mycobacteria (NTM).
New Frontier
Health Corporation (NYSE:NFH) is the operator of United Family Healthcare
(UFH), a leading private healthcare provider offering comprehensive premium
healthcare services in China through a network of private hospitals and
affiliated ambulatory clinics. UFH currently has nine hospitals and in total in
operation or under construction in all four 1st tier cities and selected 2nd
tier cities.
Trxade Group, Inc. (NasdaqCM:MEDS) is an integrated drug procurement, delivery and
healthcare platform that enables price transparency and increased profit
margins to healthcare buyers and sellers of pharmaceuticals. Founded in 2010,
Trxade Group is comprised of three synergistic operating platforms; the Trxade
B2B trading platform with 11,900 registered pharmacies, licensed virtual
Wholesale and Mail Order Pharmacy delivery capabilities using DelivMeds app.
PPD, INC. (NasdaqGS:PPD) is a leading global
contract research organization providing comprehensive, integrated drug
development, laboratory and lifecycle management services. Our customers
include pharmaceutical, biotechnology, medical device, academic and government
organizations. With offices in 46 countries and approximately 23,000
professionals worldwide, PPD applies innovative technologies, therapeutic expertise
and a firm commitment to quality to help customers bend the cost and time curve
of drug development and optimize value in delivering life-changing therapies to
improve health.
SCHRODINGER, INC. (NasdaqGS:SDGR) industry-leading computational platform to
accelerate drug discovery and materials design is deployed by leading
biopharmaceutical and industrial companies, academic institutions and
government laboratories worldwide. Schrödinger is also applying its
computational platform to a robust pipeline of drug discovery programs in
collaboration with pharmaceutical companies and has co-founded leading biotech
companies, including Nimbus Therapeutics. In addition, Schrödinger is using its
platform to advance a pipeline of internal, wholly-owned drug discovery
programs
Revolution Medicines, Inc. (NasdaqGS:RVMD) is a
clinical-stage oncology company focused on developing novel targeted therapies
to inhibit elusive high-value frontier cancer targets within notorious growth
and survival pathways, with particular emphasis on RAS and mTOR signaling
pathways. The company possesses sophisticated structure-based drug discovery
capabilities built upon deep chemical biology and cancer pharmacology know-how
and innovative, proprietary technologies that enable the creation of small
molecules tailored to unconventional binding sites. The company’s pipeline
includes RMC-4630, a clinical-stage drug candidate that is designed to
selectively inhibit the activity of SHP2.
Additionally, the company is developing a broad portfolio of inhibitors
of other key frontier oncology targets within the notorious RAS pathway, as
well as the related mTOR signaling cascade.
These include inhibitors of multiple mutant RAS proteins and SOS1, as
well as RMC-5552, a development candidate within the company’s 4EBP1/mTORC1
program currently in IND-enabling studies.
Mark A. Goldsmith CEO
CASPER SLEEP INC. (NYSE:CSPR) is a global sleep
company. The company has a full portfolio of obsessively engineered sleep
products—including mattresses, pillows, bedding, and furniture—designed
in-house by the company’s award-winning R&D team at Casper Labs in San
Francisco. In addition to its global ecommerce business, Casper owns and
operates 60 Sleep Shops across North America and its products are available at
a growing list of retailers.
ONEWATER MARINE INC. (NasdaqGM:ONEW) is one of the largest and
fastest-growing premium recreational boat retailers in the United States.
OneWater operates 63 stores throughout 11 different states, eight of which are
in the top twenty states for marine retail expenditures. OneWater offers a
broad range of products and services and has diversified revenue streams, which
include the sale of new and pre-owned boats, parts and accessories, finance and
insurance products, maintenance and repair services and ancillary services such
as boat storage.
NEXPOINT REAL ESTATE FINANCE, INC. (NYSE:NREF) is a commercial real
estate finance company that intends to elect to be treated as a real estate
investment trust. NREF's strategy is to originate, structure and invest in first
mortgage loans, mezzanine loans, preferred equity and alternative structured
financings in commercial real estate properties, as well as multifamily
commercial mortgage backed securities.
Muscle Maker, Inc. (NasdaqCM:GRIL) Founded in 1995 in
Colonia, New Jersey, Muscle Maker Grill features high quality, great tasting
food, freshly prepared with proprietary recipes. The menu, created with the
guest’s health in mind, is lean and protein based. It features all-natural
chicken, grass fed steak, lean turkey, whole wheat pasta, wraps, bowls and
more. It also offers a wide selection of fruit smoothies in a variety of
assorted flavors, protein shakes and supplements.
HUIZE HOLDING LTD (NasdaqGM:HUIZ) is a leading independent
online insurance product and service platform in China. Targeting the younger
generation, we are dedicated to serving our insurance clients for their
life-long insurance needs. Leveraging our online platform, we offer a wide
variety of insurance products with a focus on long-term life and health
insurance products, which are particularly suitable for our clients.
Bitfarms
Ltd. (TSXV:BITF.V) through its subsidiaries, engages in the mining
of cryptocurrency coins and tokens. It owns and operates server farms that
primarily support the validation and verification of transactions on the
Bitcoin blockchain, earning cryptocurrency tokens for providing this service.
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About Investorideas.com - News
that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news and press releases,
research and our own original financial content. We were one of the first
retail investor sites to cover renewable energy and cleantech stocks at
investorideas.com and our domain Renewableenergystocks.com. We were also one of
the most well- known and cited defense stock sites, featuring our domain
Homelanddefensestocks.com at its peak.
We follow the money for investors as sector sentiment
shifts and technology disrupts. Our mission is to provide investor ideas with
breaking news, resources, industry articles and interviews with leading
experts.
Learn about investing in stocks and sector trends with
our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's
original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports
and stock news column, Investor Ideas Potcasts Cannabis News
and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.
Public companies within the sectors we cover use our
news and content services to tell their story to interested investors. Paid for content is
disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news
services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media
services at Investorideas.com
Sign
up to get Investorideas.com original branded content - podcasts and commentary
in the hottest sectors
To sponsor a daily podcast for the month or to be an expert guest please
contact us!
Contact
Investorideas.com
800-665-0411
No comments:
Post a Comment